129 related articles for article (PubMed ID: 25968877)
21. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA CCAT1 rs67085638 SNP contribution to the progression of gastric cancer in a Polish population.
Olesiński T; Lutkowska A; Balcerek A; Sowińska A; Piotrowski P; Trzeciak T; Maj T; Hevelke P; Jagodziński PP
Sci Rep; 2021 Jul; 11(1):15369. PubMed ID: 34321511
[TBL] [Abstract][Full Text] [Related]
23. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
M JR; S V
Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis.
Zhang Z; Tang H; Lin J; Hu Y; Luo G; Luo Z; Cheng C; Wang P
Oncotarget; 2017 Mar; 8(10):17202-17215. PubMed ID: 28199988
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.
Li T; Zheng HM; Deng NM; Jiang YJ; Wang J; Zhang DL
World J Gastroenterol; 2017 Feb; 23(8):1450-1457. PubMed ID: 28293092
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
Hu G; Qin L; Zhang X; Ye G; Huang T
Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
[TBL] [Abstract][Full Text] [Related]
27. The clinicopathological significance of Bmi-1 expression in pathogenesis and progression of gastric carcinomas.
Lu H; Sun HZ; Li H; Cong M
Asian Pac J Cancer Prev; 2012; 13(7):3437-41. PubMed ID: 22994774
[TBL] [Abstract][Full Text] [Related]
28. Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer.
Zhang X; Tian T; Sun W; Liu C; Fang X
Medicine (Baltimore); 2017 Jun; 96(26):e7346. PubMed ID: 28658153
[TBL] [Abstract][Full Text] [Related]
29. An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis.
Wang Y; He L; Cheng Y
Clin Transl Oncol; 2018 Feb; 20(2):212-220. PubMed ID: 28681313
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
Soleyman-Jahi S; Nedjat S; Abdirad A; Hoorshad N; Heidari R; Zendehdel K
PLoS One; 2014; 10(4):e0122316. PubMed ID: 25919283
[TBL] [Abstract][Full Text] [Related]
31. Significance of BMI1 and FSCN1 expression in colorectal cancer.
Alajez NM
Saudi J Gastroenterol; 2016; 22(4):288-93. PubMed ID: 27488323
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis.
Ma JY; Liu Q
Int J Surg; 2018 Feb; 50():67-71. PubMed ID: 29329786
[TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic value of miR-92a in patients with gastric cancer.
Ren C; Wang W; Han C; Chen H; Fu D; Luo Y; Yao H; Wang D; Ma L; Zhou L; Han D; Shen M
Tumour Biol; 2016 Jul; 37(7):9483-91. PubMed ID: 26790436
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis.
Ge H; Yan Y; Guo L; He X; Yang X
Clin Chim Acta; 2017 Nov; 474():114-119. PubMed ID: 28939099
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of BMI-1 is associated with poor prognosis in cervical cancer.
Tong YQ; Liu B; Zheng HY; He YJ; Gu J; Li F; Li Y
Asia Pac J Clin Oncol; 2012 Dec; 8(4):e55-62. PubMed ID: 22898137
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis.
Jiang B; Chen JH; Yuan WZ; Ji JT; Liu ZY; Wu L; Tang Q; Shu XG
J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):278-284. PubMed ID: 27072976
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.
Shiogama S; Yoshiba S; Soga D; Motohashi H; Shintani S
Anticancer Res; 2013 Oct; 33(10):4309-17. PubMed ID: 24122997
[TBL] [Abstract][Full Text] [Related]
40. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
